1

Fisher and Paykel Healthcare

#1471

Rank

$12.97B

Marketcap

NZ New Zealand

Country

Fisher and Paykel Healthcare
Leadership team

Mr. Lewis G. Gradon (MD, CEO & Exec. Director)

Ms. Lyndal York (Chief Financial Officer)

Dr. Andrew Somervell (VP of Products & Technology)

Products/ Services
Health Care, Manufacturing, Medical Device
Number of Employees
1,000 - 20,000
Headquarters
Auckland, Auckland, New Zealand
Established
1971
Net Income
100M - 500M
Revenue
Above - 1B
Traded as
FPH.NZ
Social Media
Overview
Location
Summary
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers Airvo 2, a humidified nasal high flow system; Optiflow, a nasal high flow therapy; and F&P 850 System, a noninvasive and invasive ventilation system. In addition, it provides infant respiratory products, such as resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.
History

Fisher & Paykel began in 1934 as an importer of refrigerators, washing machines and radios. In 1938, F&P signed an agreement with Kelvinator and in the mid-1950s moved to manufacturing products using the company's own technology.The involvement in healthcare started in the late 1960s when F&P sought involvement in a business that could benefit from their growing manufacturing and electronic expertise. A prototype respiratory humidifier, developed in New Zealand for use with patients being ventilated in hospital intensive care situations, was taken to the production stage by F&P. Continuing product innovation to improve patient care and development of a world-wide distribution network are two core strengths.The company was separated and was also listed on the stock exchange on 14 November 2001. As part of a reorganization, Fisher & Paykel Industries Limited was renamed Fisher & Paykel Healthcare Corporation Limited and a new company, Fisher & Paykel Appliances Holdings Limited, was established to own F&P's appliances and finance business.In connection with the reorganisation, Fisher & Paykel Healthcare Corporation Limited listed on the Australian and New Zealand Stock Exchanges and Nasdaq. In February 2003 the Nasdaq listing was terminated.

Mission
We are committed to innovation that makes a difference. Our deepest commitment is to our customers who live with chronic disease and their families and care teams.
Vision
We strive to be the most valued health technology partner to healthcare providers and customers, providing them with the best health outcomes and experience.
Key Team

Hayden Brown (Investor Relations Mang.)

Mr. Marcus Driller (VP of Corp. & Company Sec.)

Karen Knott (Gen. Mang. of Corp. Communications)

Chris Crone (Gen. Mang. of Airvo Optiflow)

Mr. Paul N. Shearer B.Com. (Sr. VP of Sales & Marketing)

Ms. Nicola Talbot (VP of HR)

Mr. Jonathan Rhodes (VP of Supply Chain, Facilities & Sustainability)

Recognition and Awards
Fisher & Paykel Healthcare has won numerous awards and recognitions, such as being named the most innovative healthcare company in 2016, as well as being recognized as a leader in several product categories, including patient monitoring, respiratory care, warm therapy, and cooling products.
References

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Fisher and Paykel Healthcare
Leadership team

Mr. Lewis G. Gradon (MD, CEO & Exec. Director)

Ms. Lyndal York (Chief Financial Officer)

Dr. Andrew Somervell (VP of Products & Technology)

Products/ Services
Health Care, Manufacturing, Medical Device
Number of Employees
1,000 - 20,000
Headquarters
Auckland, Auckland, New Zealand
Established
1971
Net Income
100M - 500M
Revenue
Above - 1B
Traded as
FPH.NZ
Social Media